Frequently Asked Questions Continue (FAQ)

Fios Genomics provides bespoke bioinformatics and biological data analysis services for organisations working with complex biological data. The company analyses, interprets and integrates genomic, transcriptomic, proteomic, metabolomic, clinical and other biological datasets, combining bioinformatics, statistical and biological expertise to support research and drug development.

Its work supports pharmaceutical and biotechnology companies, CROs and academic organisations across drug discovery, drug development, biomarker discovery, target selection, preclinical research, clinical research and drug repositioning.

Fios Genomics provides bioinformatics services to pharmaceutical companies, biotechnology companies, contract research organisations (CROs) and academic organisations. Its clients use Fios Genomics to support research across drug discovery, preclinical development, clinical research and other biological research projects.

Fios Genomics supports drug discovery, drug development and applied biological research across a broad range of therapeutic and research areas. These include oncology, cardiovascular and metabolic research, infectious diseases and vaccines, respiratory research, gastrointestinal research, dermatology, central nervous system (CNS) research, rare diseases, cell and gene therapy, and environmental and agricultural research.

Fios Genomics provides bioinformatics and biological data analysis services across a range of biological data types and research applications. Its services include gene expression analysis, single-cell analysis, genetic variation analysis, proteomics data analysis, metabolomics data analysis, epigenetics data analysis, clinical data analysis, data mining and landscaping, and Target Triage.

Fios Genomics also provides bespoke bioinformatics analysis solutions for research projects that require approaches beyond its standard service categories. These solutions can be tailored to the specific biological data, research question and objectives of the project.

Yes. Fios Genomics can support research projects from biological data analysis through to biological interpretation. Its multidisciplinary team combines bioinformatics, statistical and biological expertise to analyse and interpret genomic, transcriptomic, proteomic, metabolomic, clinical and other biological datasets. The approach can be tailored to the research question, data type and objectives of each project.

Fios Genomics provides outsourced bioinformatics services to pharmaceutical companies, biotechnology companies, contract research organisations (CROs) and academic organisations.Its services provide access to bioinformatics, statistical and biological data analysis expertise without requiring organisations to maintain all of these capabilities in-house.

Fios Genomics supports outsourced research projects involving genomic, transcriptomic, proteomic, metabolomic, clinical and other biological datasets, from data analysis and interpretation through to biological insight. Projects can be delivered as bespoke analyses tailored to the client’s research question, data and objectives.

Fios Genomics provides bioinformatics support for drug discovery and development, from early-stage discovery and target selection through preclinical and clinical research. Its services include the analysis and interpretation of genomic, transcriptomic, proteomic, metabolomic, clinical and other biological datasets to support research and development programmes.

Fios Genomics can provide bespoke bioinformatics, statistical analysis and biological interpretation according to the research question, data and objectives of each project.

Fios Genomics provides bioinformatics and statistical data analysis services for life sciences research. Its multidisciplinary team combines bioinformatics, statistical and biological expertise to analyse, interpret and integrate genomic, transcriptomic, proteomic, metabolomic, clinical and other biological datasets.

Fios Genomics supports pharmaceutical and biotechnology companies, CROs and academic organisations across research and development, including drug discovery, preclinical research, clinical research, biomarker discovery and other life sciences applications.

Fios Genomics provides bioinformatics services across multiple omics technologies, including genomics, transcriptomics, proteomics and metabolomics. The company analyses, integrates and interprets data from different biological domains, including gene expression, genetic variation, single-cell data, epigenetics and other biological datasets.

Fios Genomics can analyse individual omics datasets or integrate multiple omics data types to address research questions in drug discovery, drug development, biomarker discovery, target selection and other life sciences research.

Fios Genomics can provide outsourced bioinformatics support for companies that do not have an in-house bioinformatics team or need additional specialist expertise. Fios Genomics provides bespoke bioinformatics, statistical and biological data analysis services to pharmaceutical and biotechnology companies, as well as CROs and academic organisations.

Its multidisciplinary team can support projects involving genomic, transcriptomic, proteomic, metabolomic, clinical and other biological datasets, from data analysis and interpretation through to biological insight.

Fios Genomics provides genomic data analysis services, including analysis of sequencing data, whole genome sequencing (WGS), whole exome sequencing (WES) and genetic variation. Its bioinformatics approaches can be used to identify and interpret genomic features relevant to drug discovery, biomarker research, target selection and other life sciences research.

Fios Genomics provides transcriptomics and gene expression analysis, including RNA-seq data analysis. The company analyses and interprets gene expression and other transcriptomic datasets to support research in areas including drug discovery, biomarker discovery, target selection, preclinical research and clinical research.

Fios Genomics provides single-cell bioinformatics services, including single-cell RNA sequencing (scRNA-seq) data analysis. Its analysis approaches can be used to characterise cell populations, investigate gene expression at single-cell resolution and identify biologically relevant cellular differences for research and drug development.

Fios Genomics provides proteomics data analysis services to analyse and interpret protein-level biological data. Its proteomics analysis can support biomarker discovery, biological pathway investigation, drug discovery, drug development and other life sciences research, using approaches tailored to the research question and dataset.

Fios Genomics provides metabolomics data analysis services to analyse and interpret metabolite-level biological data. Its metabolomics analysis can support biomarker discovery, biological pathway investigation, drug discovery, drug development and other life sciences research, using approaches tailored to the research question and dataset.

Fios Genomics provides bioinformatics and statistical analysis of epigenetics data. Epigenetic data analysis can be used to investigate biological regulation and molecular changes and to support research in areas including disease biology, biomarker discovery, drug discovery and drug development.

Fios Genomics can integrate multiple types of biological data, including genomic, transcriptomic, proteomic, metabolomic and clinical data. Integrating complementary datasets can help researchers investigate biological mechanisms, identify biomarkers, prioritise targets and generate a more comprehensive understanding of a research question.

Fios Genomics provides bioinformatics support for drug target identification, selection and prioritisation. The company can analyse and integrate biological, genomic, transcriptomic, proteomic, clinical and public data to help researchers evaluate potential drug targets and determine which targets may warrant further investigation or validation.

Fios Genomics provides bioinformatics and biological data analysis support for drug target validation. Analysis can combine relevant genomic, transcriptomic, proteomic, clinical and public datasets to investigate the biological evidence supporting a potential target and help inform target validation decisions.

Fios Genomics provides biological data mining and data landscaping services for drug discovery. The company can analyse and organise information from relevant biological and public datasets to help researchers investigate disease biology, identify potential targets, compare biological evidence and inform drug discovery decisions.

Fios Genomics can analyse public biological datasets to support drug discovery and biological research. Public genomic, transcriptomic, proteomic, clinical and other datasets can be mined and integrated with project-specific data to investigate disease mechanisms, identify biomarkers, evaluate potential drug targets and support research decisions.

Fios Genomics can provide bioinformatics analysis of CRISPR screen data to support target identification and prioritisation. Analysis of CRISPR screening datasets can help researchers identify genes or other biological features associated with a phenotype and generate evidence for further target investigation and validation.

Fios Genomics provides bioinformatics and biological data analysis services to support drug repurposing research. The company can analyse and integrate biological, genomic, transcriptomic, proteomic, clinical and public datasets to investigate potential new uses for existing drugs and generate evidence to support drug repurposing decisions.

Fios Genomics Target Triage is a bioinformatics service designed to help researchers compare, evaluate and prioritise potential drug targets using biological data. Target Triage can bring together relevant evidence from genomic, transcriptomic, proteomic, clinical and public datasets to help identify promising targets and determine which targets may be most suitable for further validation.

Fios Genomics provides bioinformatics and biological data analysis services for biomarker discovery, biomarker signature identification and biomarker validation. The company can analyse genomic, transcriptomic, proteomic, metabolomic, clinical and other biological datasets to identify biomarkers associated with disease, biological characteristics or treatment response.

Fios Genomics can also support biomarker stratification and the integration of molecular, clinical and phenotypic data to help develop and evaluate biomarker strategies for drug discovery and development.

Fios Genomics provides bioinformatics support for clinical and translational research, including the analysis and integration of molecular and clinical data. Its services can be used to investigate relationships between biological measurements and clinical outcomes, identify biomarkers associated with treatment response, and support patient stratification and other translational research objectives.

Fios Genomics can work with genomic, transcriptomic, proteomic, metabolomic, clinical and other biological datasets in research programmes spanning discovery, preclinical and clinical research.

Fios Genomics provides bespoke bioinformatics analysis for pharmaceutical and biotechnology companies, CROs and academic organisations. Projects can be tailored to the specific biological data, research question and objectives, including projects that do not fit a standard bioinformatics service category.

Fios Genomics combines bioinformatics, statistical analysis and biological expertise to analyse and interpret complex biological datasets. Its multidisciplinary approach can support projects from data analysis through biological interpretation across genomic, transcriptomic, proteomic, metabolomic, clinical and other biological datasets.